CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 1 filers reported holding CLOVIS ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,777,000 | -13.9% | 39,081 | 0.0% | 0.03% | -18.8% |
| Q1 2018 | $2,063,000 | -22.4% | 39,081 | 0.0% | 0.03% | -22.0% |
| Q4 2017 | $2,658,000 | -16.9% | 39,081 | +0.7% | 0.04% | -21.2% |
| Q3 2017 | $3,198,000 | -12.0% | 38,813 | 0.0% | 0.05% | -17.5% |
| Q2 2017 | $3,634,000 | +135.2% | 38,813 | +131.0% | 0.06% | +70.3% |
| Q3 2015 | $1,545,000 | – | 16,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |